Dr. Melanie Shapiro (Todd Brusko lab) presented at IDS (International Immunology Diabetes Society) meeting 2024 in Bruges, Belgium and was voted top 3. IDS 2024 TYK2 inhibition enhances regulatory T cell differentiation and function while preventing Th1 and Th17 differentiationKaroliina TuomelaBC Children’s Hospital Research…
UF EPI Interim Director Marco Salemi discusses the future of the institute…
Dr. Timothy Garrett Dr. David Ostrov Dr. Weizhou Zhang Dr. Allison Andrews (not pictured) Dr. Servio Ramirez (not pictured)…
Second Round of Applause for UF PostdocsRevisiting UF Postdoctoral Appreciation Week 2024 Though UF Postdoctoral Appreciation Week 2024 (September 16-20) may be in our rearview mirrors as we settle back in classroom, library, and lab, the spirit that it kindled drives to give…
Topics In Cancer Seminar…
The combination of two over-the-counter compounds tested in mice significantly improved their chances of surviving the virus that causes COVID-19, University of Florida researchers have found… Full Article: https://ufhealth.org/news/2023/combination-of-two-common-compounds-improves-covid-survival-in-mice-uf-researchers-find Author: Doug Bennett…
The Emerging Pathogens Institute appoints five new associate directors » Emerging Pathogens Institute » University of Florida (ufl.edu) Professor Marco Salemi, Ph.D., serves as EPI Associate Director for Research Initiatives. In this role, Salemi is developing strategies to increase collaborations on large-scale extramural funding opportunities. He aims to…
Lei Wang Title: Degrading Nuclear Receptor NR4A1 by Proteolysis-Targeting Chimeras for Cancer Therapy Abstract: Cellular genes and proteins change during tumor microenvironment (TME) formation. Some proteins overexpression in cancer cells and certain tumor-infiltrating immune cells causes immune suppression in TME and is correlated with poor prognosis. Ideally, we can…
William Winter MD has been selected by the medical students as the Phase 1 Teacher of the Year for the College of Medicine. Dr. Winter is a Professor of Pathology, Immunology and Laboratory Medicine, Pediatrics, and Molecular Genetics and Microbiology. He has an extensive role in teaching first and second…
Weizhou Zhang, Ph.D., a professor in the department of pathology, immunology & laboratory medicine in the University of Florida College of Medicine, has received a $2.5 million R01 grant from the National Cancer Institute to study a novel therapeutic strategy to treat renal clear cell carcinomas. Full Article:…
